TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Sever Pharma Solutions AB
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
407,559
|
347,468
|
326,423 |
Financial expenses |
3,852
|
2,910
|
2,139 |
Earnings before taxes |
11,282
|
20,332
|
17,418 |
EBITDA |
29,842
|
35,491
|
27,492 |
Total assets |
365,505
|
331,357
|
318,603 |
Current assets |
186,582
|
143,352
|
125,250 |
Current liabilities |
129,459
|
68,547
|
53,596 |
Equity capital |
220,953
|
165,500
|
152,576 |
- share capital |
6,682
|
7,271
|
7,412 |
Employees (average) |
312
|
278
|
256 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
60.5%
|
49.9%
|
47.9% |
Turnover per employee |
1,306
|
1,250
|
1,275 |
Profit as a percentage of turnover |
2.8%
|
5.9%
|
5.3% |
Return on assets (ROA) |
4.1%
|
7.0%
|
6.1% |
Current ratio |
144.1%
|
209.1%
|
233.7% |
Return on equity (ROE) |
5.1%
|
12.3%
|
11.4% |
Change turnover |
88,236
|
27,224
|
68,501 |
Change turnover % |
28%
|
9%
|
27% |
Chg. No. of employees |
34
|
22
|
55 |
Chg. No. of employees % |
12%
|
9%
|
27% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.